Your browser doesn't support javascript.
loading
Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS.
Huls, Gerwin; Chitu, Dana A; Pabst, Thomas; Klein, Saskia K; Stussi, Georg; Griskevicius, Laimonas; Valk, Peter J M; Cloos, Jacqueline; van de Loosdrecht, Arjan A; Breems, Dimitri; van Lammeren-Venema, Danielle; van Zeventer, Isabelle; Boersma, Rinske; Jongen-Lavrencic, Mojca; Fehr, Martin; Hoogendoorn, Mels; Manz, Markus G; Söhne, Maaike; van Marwijk Kooy, Rien; Deeren, Dries; van der Poel, Marjolein W M; Legdeur, Marie Cecile; Tick, Lidwine; Chalandon, Yves; Ammatuna, Emanuele; Blum, Sabine; Löwenberg, Bob; Ossenkoppele, Gert J.
Affiliation
  • Huls G; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
  • Chitu DA; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Pabst T; Department of Oncology, University Hospital, Inselspital, and University of Bern, Bern, Switzerland.
  • Klein SK; Department of Hematology, Meander Hospital Amersfoort, Amersfoort, The Netherlands.
  • Stussi G; Department of Hematology, Ospedale Regionale, Bellinzona, Switzerland.
  • Griskevicius L; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania.
  • Valk PJM; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Cloos J; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • van de Loosdrecht AA; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Breems D; Department of Hematology, ZNA Stuivenberg/Middelheim, Antwerp, Belgium.
  • van Lammeren-Venema D; Department of Hematology, Hagaziekenhuis, Den Haag, The Netherlands.
  • van Zeventer I; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
  • Boersma R; Department of Hematology, Amphia Hospital, Breda, The Netherlands.
  • Jongen-Lavrencic M; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Fehr M; Department of Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Hoogendoorn M; Department of Hematology, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
  • Manz MG; Department of Medical Oncology and Hematology, Universitätsspital Zurich, Zurich, Switzerland.
  • Söhne M; Department of Hematology, Antonius Hospital, Nieuwegein, The Netherlands.
  • van Marwijk Kooy R; Department of Hematology, Isala Hospital, Zwolle, The Netherlands.
  • Deeren D; Department of Hematology, AZ Delta Roeselare, Roeselare, Belgium.
  • van der Poel MWM; Department of Hematology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Legdeur MC; Department of Hematology, Medical Spectrum Twente, Enschede, The Netherlands.
  • Tick L; Department of Hematology, Maxima Medical Center, Veldhoven, The Netherlands.
  • Chalandon Y; Division of Hematology, University Hospital Genève and Faculty of Medicine, University of Genève, Genève, Switzerland; and.
  • Ammatuna E; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
  • Blum S; Service and Central Laboratory of Hematology, Department of Oncology and Department of Laboratory Medicine and Pathology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
  • Löwenberg B; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Ossenkoppele GJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Blood Adv ; 4(18): 4267-4277, 2020 09 22.
Article in En | MEDLINE | ID: mdl-32915972
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Blood Adv Year: 2020 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Blood Adv Year: 2020 Type: Article Affiliation country: Netherlands